Intrinsiqs

Is Definium Therapeutics, Inc. overvalued?

Definium Therapeutics, Inc. (DFTX) — key valuation metrics and fundamentals.

No verdict
Price
$32.08
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$4.39B
Dividend yield
0.0%
Return on equity
-54.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares DFTX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.